Cargando…

Developing and sustaining India's capacity for preclinical drug discovery

Detalles Bibliográficos
Autores principales:	Lewis, David I., Patel, Bhagirath K., Kumar, B. Dinesh, Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302698/ https://www.ncbi.nlm.nih.gov/pubmed/30636824 http://dx.doi.org/10.4103/ijp.IJP_641_18

Ejemplares similares

Alliance between the International Union of Basic and Clinical Pharmacology and the Indian Pharmacological Society for Health, Education, Drug Discovery, and Development in India
por: Spedding, Michael, et al.
Publicado: (2016)

Experience of an academic institute in importing a novel preclinical drug into India
por: Kumar, M. Praveen, et al.
Publicado: (2017)

Integrative omics – An arsenal for drug discovery
por: Singh, Rahul Soloman, et al.
Publicado: (2022)

Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023)

Cosmetovigilance in India: Need of the day
por: Sarma, Phulen, et al.
Publicado: (2017)

Imaging techniques in drug development
por: Gupta, Shreya, et al.
Publicado: (2022)

Three-dimensional drugs: A new era in the pharmaceutical development
por: Kumar, Harish, et al.
Publicado: (2017)

Marathon mice: Researcher view on potential roles in preclinical research
por: Kumaravel, J., et al.
Publicado: (2021)

Translational research: Bridging the gap between preclinical and clinical research
por: Mahalmani, Vidya, et al.
Publicado: (2022)

Orphan drugs: Indian perspective
por: Kumar, Harish, et al.
Publicado: (2017)

Impact of Organization for Economic Co-Operation and Development (OECD) principles of Good Laboratory practices (GLP) in India
por: Kapoor, Ekta, et al.
Publicado: (2021)

Understanding the challenges and ethical aspects of compassionate use of drugs in emergency situations
por: Goyal, Pardeep Kumar, et al.
Publicado: (2020)

Drugs in sport: The curse of doping and role of pharmacologist
por: Mahendru, Dhruv, et al.
Publicado: (2019)

Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019)

Frontiers in New Drug Discovery: From Molecular Targets to Preclinical Trials
por: Aminin, Dmitry
Publicado: (2023)

Novel targets for drug discovery in celiac disease
por: Singh, Rahul Soloman, et al.
Publicado: (2019)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

Clinical trials for food – The gray areas: Developing countries' perspective
por: Prabha, Praisy K., et al.
Publicado: (2023)

Changing trends in pharmacology…
por: Medhi, Bikash
Publicado: (2017)

Antiepileptic drugs in development pipeline: A recent update
por: Kaur, Harjeet, et al.
Publicado: (2016)

Transforming capacity-strengthening in an era of sustainable development
por: Heerdegen, Anne Christine Stender
Publicado: (2020)

mHealth technologies in clinical trials: Opportunities and challenges
por: Kakkar, Ashish Kumar, et al.
Publicado: (2018)

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Photopharmacology
por: Sarma, Phulen, et al.
Publicado: (2017)

New undergraduate medical education curriculum
por: Mittal, Niti, et al.
Publicado: (2022)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
por: Thota, Prasad, et al.
Publicado: (2018)

Intellectual property rights and Indian pharmaceutical industry: Present scenario
por: Prakash, Ajay, et al.
Publicado: (2018)

Computational Approaches in Preclinical Studies on Drug Discovery and Development
por: Wu, Fengxu, et al.
Publicado: (2020)

Ecopharmacovigilance: An issue urgently to be addressed
por: Medhi, Bikash, et al.
Publicado: (2012)

Modulation of endocannabinoid system: Success lies in the failures
por: Kumar, Subodh, et al.
Publicado: (2018)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

An intervention to evaluate & improve handling of cancer drugs in a tertiary care hospital in India
por: Kiran, D V R, et al.
Publicado: (2017)

Novel therapeutic approaches toward Hantaan virus and its clinical features’ similarity with COVID-19
por: Singh, Harvinder, et al.
Publicado: (2020)

Connectomics: A pharmacologic viewpoint
por: Harikrishnareddy, Dibbanti, et al.
Publicado: (2018)

An urgent need for experimental animal model of autism in drug development
por: Ruhela, Rakesh K, et al.
Publicado: (2015)

Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2022)

Applications of biophysical techniques in drug discovery and development
por: Verbić, Tatjana Ž.
Publicado: (2019)

Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy
por: Sarma, Phulen, et al.
Publicado: (2018)

Pattern of pharmacological research from the last six decades
por: Joshi, Rupa, et al.
Publicado: (2019)

Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sugti410ek9fl70hbkv4726l0l